Search

Your search keyword '"Scaglioni, Mario F"' showing total 476 results
Start Over Author "Scaglioni, Mario F"
476 results on '"Scaglioni, Mario F"'

31. Unlocking the Power of Benchmarking: Real-World-Time Data Analysis for Enhanced Sarcoma Patient Outcomes

Author

Fuchs, Bruno; https://orcid.org/0000-0001-6453-3947, Schelling, Georg, Elyes, Maria, Studer, Gabriela, Bode-Lesniewska, Beata; https://orcid.org/0000-0002-3329-4186, Scaglioni, Mario F; https://orcid.org/0000-0001-5289-9140, Giovanoli, Pietro, Heesen, Philip; https://orcid.org/0000-0002-5090-4935, On Behalf Of The SwissSarcomaNetwork, Fuchs, Bruno; https://orcid.org/0000-0001-6453-3947, Schelling, Georg, Elyes, Maria, Studer, Gabriela, Bode-Lesniewska, Beata; https://orcid.org/0000-0002-3329-4186, Scaglioni, Mario F; https://orcid.org/0000-0001-5289-9140, Giovanoli, Pietro, Heesen, Philip; https://orcid.org/0000-0002-5090-4935, and On Behalf Of The SwissSarcomaNetwork

Abstract

Benchmarking is crucial for healthcare providers to enhance quality and efficiency, notably for complex conditions like sarcomas. Multidisciplinary teams/sarcoma boards (MDT/SBs) are vital in sarcoma management, but differences in their processes can affect patient outcomes and treatment costs, despite adherence to international guidelines. To address this issue, this study aimed to compare two MDT/SBs and establish an interoperable digital platform, Sarconnector$^{®}$, for real-time-world data assessment and automated analysis. The study included 983 patients, 46.0% of whom female, with a median age of 58 years, and 4.5% of patients presented with metastasis at diagnosis. Differences were observed in the number of first-time presentations, follow-up presentations, primary sarcomas, biopsies and chemotherapy indications between the two MDT/SB. The results highlight the importance of benchmarking and utilizing a harmonized data approach, such as the RWT approach provided by the Sarconnector$^{®}$, to standardize and evaluate quality and cost metrics. By identifying areas of improvement and making data-driven decisions on the meta-level, healthcare providers can optimize resources and improve patient outcomes. In conclusion, benchmarking with the RWT harmonized data approach provided by the Sarconnector$^{®}$ can help healthcare providers improve the overall effectiveness of the healthcare system and achieve better outcomes for their patients in terms of both outcomes and costs.

Published
2023

49. Unlocking the Power of Benchmarking: Real-World-Time Data Analysis for Enhanced Sarcoma Patient Outcomes.

Author

Fuchs, Bruno, Schelling, Georg, Elyes, Maria, Studer, Gabriela, Bode-Lesniewska, Beata, Scaglioni, Mario F., Giovanoli, Pietro, and Heesen, Philip

Subjects
ELECTRONIC data interchange, COMPUTERS, BIOPSY, CANCER chemotherapy, METASTASIS, MEDICAL care costs, HEALTH outcome assessment, ARTIFICIAL intelligence, MACHINE learning, BENCHMARKING (Management), VALUE-based healthcare, CANCER patients, COMPARATIVE studies, HEALTH care teams, QUALITY assurance, AUTOMATION, DESCRIPTIVE statistics, DATA analysis, DATA analytics, INTEGRATED health care delivery, SARCOMA, CANCER patient medical care
Abstract

Simple Summary: Benchmarking is a crucial tool for healthcare providers to improve quality and efficiency, especially for complex conditions like sarcomas. Sarcomas are a type of cancer that require a multidisciplinary approach to treatment. However, despite adherence to international guidelines, differences in the processes used by these boards can affect patient outcomes and treatment costs. This study compared two multidisciplinary teams/sarcoma tumor boards and established an interoperable digital platform, Sarconnector®, for real-world time (RWT) data assessment and automated analysis. Differences were obtained in various areas, such as first-time presentations, follow-up presentations, primary sarcomas, biopsies and chemotherapy indications. By identifying areas of improvement and making data-driven decisions on the meta-level, healthcare providers can optimize resources and improve patient outcomes. Benchmarking with the RWT harmonized data approach provided by the Sarconnector® can help healthcare providers achieve better outcomes for their patients and improve the overall effectiveness of the healthcare system. Benchmarking is crucial for healthcare providers to enhance quality and efficiency, notably for complex conditions like sarcomas. Multidisciplinary teams/sarcoma boards (MDT/SBs) are vital in sarcoma management, but differences in their processes can affect patient outcomes and treatment costs, despite adherence to international guidelines. To address this issue, this study aimed to compare two MDT/SBs and establish an interoperable digital platform, Sarconnector®, for real-time-world data assessment and automated analysis. The study included 983 patients, 46.0% of whom female, with a median age of 58 years, and 4.5% of patients presented with metastasis at diagnosis. Differences were observed in the number of first-time presentations, follow-up presentations, primary sarcomas, biopsies and chemotherapy indications between the two MDT/SB. The results highlight the importance of benchmarking and utilizing a harmonized data approach, such as the RWT approach provided by the Sarconnector®, to standardize and evaluate quality and cost metrics. By identifying areas of improvement and making data-driven decisions on the meta-level, healthcare providers can optimize resources and improve patient outcomes. In conclusion, benchmarking with the RWT harmonized data approach provided by the Sarconnector® can help healthcare providers improve the overall effectiveness of the healthcare system and achieve better outcomes for their patients in terms of both outcomes and costs. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results